Rituximab

Bioassay GmbH offers rituximab. The antibody dependent cell mediated cytotoxicity (adcc) is a mechanism of immune defense attributed to the mode of action of several tab, in particular tumor cell targeting. In adcc, tumor cells (recognized by tab)are targeted by natural killer cells by their fc?riii (cd16) receptor binding to the fc portion of the tab followed by lysis of the target (tumor) cell. Contact us for more infrmation.